Breaking News Instant updates and real-time market news.

CARG

CarGurus

$29.82

0.27 (0.91%)

, WPRT

Westport

$3.00

-0.08 (-2.60%)

17:24
11/14/17
11/14
17:24
11/14/17
17:24

On The Fly: After Hours Movers

UP AFTER EARNINGS: CarGurus (CARG), up 9.8%... Westport (WPRT), up 8.7%... Synacor (SYNC), up 8.7%... Beazer Homes (BZH), up 4.4%. ALSO HIGHER: Lam Research (LRCX), up 2.1% after it announced a $2B share buyback plan and raised its quarterly dividend 11%... HP Enterprise (HPE), up 1.4% Greenlight Capital disclosed that it increased its stake in the company... Synchrony Financial (SYF), up 1.3% after Berkshire Hathaway raised its stake in the company. DOWN AFTER EARNINGS: A-Mark Precious Metals (AMRK), down 12.6%... Macom (MTSI), down 7.7%... NovaBay (NBY), down 5.6%. ALSO LOWER: Achillion (ACHN), down 8.4% after it filed to sell 18.4M shares of common stock for holders... Genpact (G), down 2.8% after it filed to sell 10M shares of common stock for holders.

CARG

CarGurus

$29.82

0.27 (0.91%)

WPRT

Westport

$3.00

-0.08 (-2.60%)

SYNC

Synacor

$2.30

-0.175 (-7.07%)

BZH

Beazer Homes

$21.56

0.7 (3.36%)

LRCX

Lam Research

$208.64

-0.59 (-0.28%)

HPE

HP Enterprise

$13.27

-0.21 (-1.56%)

SYF

Synchrony

$32.56

-0.03 (-0.09%)

AMRK

A-Mark Precious Metals

$15.20

-0.01 (-0.07%)

MTSI

Macom

$36.61

0.04 (0.11%)

NBY

NovaBay

$4.45

0.255 (6.08%)

ACHN

Achillion

$3.69

-0.16 (-4.16%)

G

Genpact

$31.06

-0.04 (-0.13%)

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

  • 20

    Nov

  • 21

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 14

    Dec

  • 15

    Nov

CARG CarGurus
$29.82

0.27 (0.91%)

11/06/17
11/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CarGurus (CARG) was initiated with a Sector Perform at RBC Capital, a Market Perform at Raymond James and JMP Securities, and a Neutral at Goldman Sachs. 2. OrthoPediatrics (KIDS) was initiated with a Buy at Stifel and BTIG while being initiated with an Overweight at Piper Jaffray. 3. Rimini Street (RMNI) initiated with an Outperform at Cowen. 4. Rigel Pharmaceuticals (RIGL) assumed with a Buy at H.C. Wainwright. 5. Great Elm Capital (GECC) initiated with a Neutral at Janney Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/17
RBCM
11/06/17
INITIATION
Target $33
RBCM
Sector Perform
CarGurus initiated with a Sector Perform at RBC Capital
RBC Capital analyst Mark Mahaney initiated CarGurus with a Sector Perform rating and a price target of $33, saying the company's investment positives are well-balanced against risks. Mahaney notes that as one of the leading online auto marketplaces, CarGurus has a large market opportunity amid Borrell Research-estimated US Auto Advertising market expansion from $37B to $47B by 2021. The analyst also says the company has a compelling business model, with 100% revenue growth in 2016 and another 70% in the first half of this year. Mahaney adds that CarGurus has ample room to grow its international business, citing its recent launch in Germany and pending status in other Europe markets.
11/06/17
JMPS
11/06/17
INITIATION
JMPS
Market Perform
CarGurus initiated with a Market Perform at JMP Securities
JMP Securities analsyt Ronald Josey initiated CarGurus with a Market Perform primarily due to valuation concerns.
11/06/17
RAJA
11/06/17
INITIATION
RAJA
Market Perform
CarGurus initiated with a Market Perform at Raymond James
Raymond James analyst Aaron Kessler initiated CarGurus with a Market Perform due to valuation and notes shares are up approximately 100% since its IPO.
WPRT Westport
$3.00

-0.08 (-2.60%)

10/05/17
LSCM
10/05/17
NO CHANGE
Target $5
LSCM
Buy
Westport price target raised to $5 from $3 at Lake Street
Lake Street analyst Robert Brown raised his price target for Westport Fuel Systems to $5 saying Volvo's launch of two LNG fueled truck versions in the European market using Westport's HPDI system is a "watershed moment." End markets seemed primed for a viable alternative to diesel and short payback periods are attractive to customers, Brown tells investors in a research note. Further, Volvo's investment to launch the product gives the analyst confidence that market demand is real. The analyst keeps a Buy rating on Westport shares.
10/03/17
CHLM
10/03/17
NO CHANGE
CHLM
Volvo LNG launch a 'significant milestone' for Westport, says Craig-Hallum
Craig-Hallum analyst Eric Stine said Westport Fuel Systems' (WPRT) high-pressure direct injection technology is "finally" being launched in LNG trucks by Volvo (VOLVY), which he views as a "significant milestone" that will have a meaningful financial impact for Westport. The analyst, who also thinks the launch will accelerate the HPDI plans of other OEMs, reiterates his Buy rating on Westport shares.
08/16/17
OPCO
08/16/17
INITIATION
Target $3
OPCO
Outperform
Westport initiated with an Outperform at Oppenheimer
Oppenheimer analyst Colin Rusch initiated Westport with an Outperform and $3 price target.
SYNC Synacor
$2.30

-0.175 (-7.07%)

06/26/17
CHLM
06/26/17
NO CHANGE
Target $5
CHLM
Buy
AT&T portal ramping earlier than expected for Synacor, says Craig-Hallum
Craig-Hallum analyst George Sutton said Synacor's (SYNC) launch of the AT&T.net (T) portal has ramped up a bit earlier than he'd anticipated and noted that its website metrics suggest it is being well received by users. Sutton, who thinks success from this initiative should lead to a significant acceleration in the third quarter, keeps a Buy rating and $5 price target on Synacor shares.
08/10/17
08/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Unilever (UN, UL) downgraded to Underperform from Sector Perform at RBC Capital with analyst James Edwardes Jones citing valuation and his belief that the company may not meet its 2020 targets. 2. Masonite (DOOR) downgraded to Equal Weight from Overweight at Stephens. 3. Synacor (SYNC) downgraded to Hold from Buy at Craig-Hallum with analyst Jason Kreyer saying he is "unequivocally" disappointed that the AT&T (T)portal launch has not yet monetized at a rate anticipated. 4. NetEase (NTES) downgraded to Underperform from Outperform at CLSA. 5. Achillion (ACHN) downgraded to Neutral from Outperform at Baird with analyst Brian Skorney saying the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
08/10/17
DOWNGRADE
Target $4

Hold
Synacor downgraded to Hold at Craig-Hallum
As previously reported, Craig-Hallum analyst Jason Kreyer downgraded Synacor (SYNC) to Hold from Buy saying he is "unequivocally" disappointed that the AT&T (T)portal launch has not yet monetized at a rate anticipated. The monetization engines will be cranked up slower than expected as the team is testing ads to determine how best to monetize the site, a process likely to result in a six month longer ramp than originally expected, he contends. The analyst also lowered his price target on the shares to $4 from $5.
08/10/17
CHLM
08/10/17
DOWNGRADE
CHLM
Hold
Synacor downgraded to Hold from Buy at Craig-Hallum
BZH Beazer Homes
$21.56

0.7 (3.36%)

09/14/17
JPMS
09/14/17
UPGRADE
Target $21
JPMS
Overweight
Beazer Homes upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Beazer Homes to Overweight saying the relative valuation looks attractive. The analyst expects Beazer to post above average gross and operating margin expansion. He raised his price target for the shares to $21 from $14.50.
09/14/17
JPMS
09/14/17
UPGRADE
Target $32
JPMS
Overweight
Century Communities upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Century Communities (CCS) to Overweight saying the relative valuation looks attractive. The analyst expects Century to post above average gross and operating margin expansion. He raised his price target for the shares to $32 from $28. Rehaut this morning also upgraded Beazer Homes (BZH) to Overweight and downgraded Toll Brothers (TOL) to Neutral. His top pick in the Homebuilding sector is PulteGroup (PHM).
09/14/17
09/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VMware (VMW) upgraded to Overweight from Equal Weight at Barclays with analyst Raimo Lenschow saying the stock looks undervalued as the thesis that VMware will lose market share as workloads move to the public cloud no longer seems valid, Lenschow tells investors in a research note. 2. Ryder (R) upgraded to Overweight from Sector Weight at KeyBanc with analyst Todd Fowler saying he believes the company's earnings path is improving after channel checks indicated near-term rental activity is at the high end of seasonal variations. 3. Century Communities (CCS) and Beazer Homes (BZH) were upgraded to Overweight from Neutral at JPMorgan. 4. Southern Company (SO) upgraded to Buy from Neutral at Guggenheim. 5. Air Products (APD) upgraded to Positive from Neutral at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
08/08/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dean Foods (DF) was downgraded to Neutral from Overweight at JPMorgan and to Equal Weight from Overweight at Stephens. 2. Armstrong Flooring (AFI) downgraded to Hold from Buy at Gabelli. 3. Plains All American (PAA) was downgraded to Neutral from Outperform at Baird and to Sector Perform at Scotia Howard Weil. 4. Beazer Homes (BZH) downgraded to Neutral from Outperform at Wedbush with analyst Jay McCanless citing valuation and lack of near-term catalysts. 5. Noble Corp. (NE) downgraded to Hold from Buy at Societe Generale with analyst Edward Muztafago saying the weak pricing environment will limit near-term improvement in the deepwater market and believes it will be second half 2018, at the earliest, before new project work picks up more materially. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LRCX Lam Research
$208.64

-0.59 (-0.28%)

10/18/17
FBCO
10/18/17
NO CHANGE
Target $245
FBCO
Outperform
Lam Research price target raised to $245 from $214 at Credit Suisse
Credit Suisse analyst Farhan Ahmad raised his price target for Lam Research to $245 from $214 following quarterly results. The analyst reiterates an Outperform rating on the shares.
10/18/17
COWN
10/18/17
NO CHANGE
Target $32
COWN
Market Perform
Ultra Clean should have a very strong year, says Cowen
Cowen analyst Karl Ackerman said the strong commentary out of Lam Research (LRCX) and Applied Materials (AMAT) suggests this should be a very strong year for Ultra Clean (UCTT). He said the company sits in a unique position within the OLED supply chain, which is in the midst of a technology transition. Ackerman maintained his Market Perform rating and raised his price target to $32 from $28 on Ultra Clean shares.
10/18/17
NEED
10/18/17
NO CHANGE
Target $235
NEED
Buy
Lam Research price target raised to $235 from $220 at Needham
Needham analyst Y. Edwin Mok raised his price target on Lam Research to $235 and maintained his Buy rating following earnings, noting that management comments helped to soothe concerns over a near term peak. Mok says the company will continue to leverage is exposure to memory and will also benefit from progress in penetrating foundry/logic applications, as the Q3 shipments in that space rose to 34% from 27% of the total last quarter.
10/18/17
COWN
10/18/17
NO CHANGE
Target $38
COWN
Outperform
Ichor Holdings price target raised to $38 from $27 at Cowen
Cowen analyst Karl Ackerman raised his price target on Ichor Holdings (ICHR) to $38 from $27. He said the Street assumed zero growth in its core business. However, given NAND WFE pricing is moving higher and positive shipment commentary from Lam Research (LRCX) and Applied Materials (AMAT), Street estimates appear too low, said Ackerman, who reiterated his Outperform rating on Ichor Holdings shares.
HPE HP Enterprise
$13.27

-0.21 (-1.56%)

11/14/17
DADA
11/14/17
NO CHANGE
Target $53
DADA
Buy
NetApp offers attractive value investment opportunity, says DA Davidson
DA Davidson analyst Mark Kelleher raised his price target on NetApp (NTAP) to $53 from $51 and kept his Buy rating ahead of tomorrow's Q2 earnings. Kelleher says the company has a rejuvenated product line that spans many new markets, including Cloud and Flash, while also demonstrating a commitment to its stock buyback program. The analyst expects Q2 to show continued strong sales of flash-based systems as the company takes market share from Dell/EMC and Hewlett-Packard (HPE).
10/27/17
PIVT
10/27/17
INITIATION
Target $180
PIVT
Buy
IBM initiated with a Buy at Pivotal Research
Pivotal Research analyst Lou Miscioscia initiated IBM (HPE) with a Buy and $180 price target. The analyst prefers IBM to HP Enterprise (HPE) due to its more complete IT approach led by services and with Digital Hardware/software solutions. Miscioscia said IBM's valuation is at the low end of peers and after years of turnaround efforts is finally positioned to grow.
10/20/17
10/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PulteGroup (PHM) downgraded to Sell from Neutral at Citi with analyst Will Randow saying the 49% year-to-date share rally has been exaggerated by the company's $1B share repurchase program that likely will sunset at year-end. 2. Celgene (CELG) was downgraded to Neutral from Buy at Citi and to Neutral from Outperform at Baird. 3. HP Enterprise (HPE) downgraded to Neutral from Buy at UBS with analyst Steven Milunovich saying the company's streamlining plans make sense but could prove disruptive and its pivot to higher margin revenue will take time. 4. Regeneron (REGN) downgraded to Underweight from Equal Weight at Barclays with analyst Geoff Meacham saying he believes expectations for Dupixent in atopic dermatitis and asthma are too high. 5. Bojangles (BOJA) downgraded to Market Perform from Outperform at Cowen with analyst Andrew Charles saying his survey data leaves him concerned whether the company can successfully implement value efforts to drive traffic amid intensified industry focus on value, which is likely to persist through 2018. Charles lowered his price target to $14 from $20 on Bojangles shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/17
WELS
11/14/17
INITIATION
Target $15
WELS
Market Perform
HP Enterprise resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Aaron Rakers resumed coverage of HP Enterprise with a Market Perform rating and $15 price target.
SYF Synchrony
$32.56

-0.03 (-0.09%)

10/10/17
WELS
10/10/17
INITIATION
WELS
Market Perform
Synchrony resumed coverage with a Market Perform at Wells Fargo
Wells Fargo analyst Donald Fandetti resumed coverage of Synchrony with a Market Perform rating and $33 price target, citing "heightened investor concerns around credit and the health of retailers."
10/06/17
BOFA
10/06/17
DOWNGRADE
Target $33
BOFA
Neutral
Synchrony downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Kenneth Bruce downgraded Synchrony to Neutral and cut its price target to $33 from $35 citing the lack of 2018 earnings visibility. The analyst said better visibility into credit and the earnings trajectory would serve as a catalyst.
09/08/17
MSCO
09/08/17
DOWNGRADE
Target $32
MSCO
Equal Weight
Synchrony downgraded to Equal Weight on subprime risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Betsy Graseck downgraded Synchrony (SYF) to Equal Weight from Overweight, stating that pressure on subprime consumers is rising, leading her to raise her subprime card loss estimates 5% and lower her EPS estimates for the company and peer Capital One (COF), which she also downgraded this morning. Capital One has a 36% mix of subprime credit cards, while 28% of Synchrony's credit cards are subprime, Graseck noted. She has a $32 price target on Synchrony shares.
09/08/17
MSCO
09/08/17
DOWNGRADE
MSCO
Equal Weight
Synchrony downgraded to Equal Weight from Overweight at Morgan Stanley
AMRK A-Mark Precious Metals
$15.20

-0.01 (-0.07%)

03/17/17
RILY
03/17/17
INITIATION
Target $18.75
RILY
Neutral
A-Mark Precious Metals resumed with a Neutral at B. Riley
B. Riley analyst Ian Corydon resumed coverage of A-Mark Precious Metals with a Neutral rating and $18.75 price target.
MTSI Macom
$36.61

0.04 (0.11%)

10/17/17
NEED
10/17/17
NO CHANGE
Target $45
NEED
Buy
Macom looks oversold after yesterday's selloff, says Needham
Needham analyst N. Quinn Bolton believes Macom Technology Solutions looks oversold following yesterday's 12% selloff. Stifel's downgrade raises many of the bear case themes that have been around for several quarters, Bolton tells investors in a research note. He does not see a lot of new news. The analyst, however, agrees that consensus revenue estimates for 2018 look aggressive and reduced his numbers accordingly. He also dropped his price target for Macom shares to $45 from $56. Bolton keeps a Buy rating on the name.
10/17/17
DADA
10/17/17
INITIATION
Target $45
DADA
Neutral
MACOM initiated with a Neutral at DA Davidson
DA Davidson analyst Mark Kelleher initiated MACOM with a Neutral rating and a $45 price target, noting the recent acquisition of AppliedMicro adds complementary mix-signal capabilities along with ability to address the QSPF28 transceiver market. Kelleher says the company should be able to maintain mid-teens growth amid continued rapid adoption of 100 GB Etherner in data center and service provider markets.
10/16/17
DADA
10/16/17
INITIATION
Target $45
DADA
Neutral
MACOM initiated with a Neutral at DA Davidson
DA Davidson analyst Mark Kelleher initiated MACOM with a Neutral and $45 price target saying he expects slow demand from China to limit organic revenue expansion for the next several quarters.
10/16/17
10/16/17
DOWNGRADE
Target $43

Hold
MACOM downgraded to Hold at Stifel
As previously reported, Stifel analyst Tore Svanberg downgraded MACOM to Hold from Buy and cut his price target on the stock to $43 from $57. He believes China weakness will persist at least through year-end while he also thinks the company's capital management has been "poor" and it has struggled to generate any material cash flows, leading him to lose confidence in management.
NBY NovaBay
$4.45

0.255 (6.08%)

02/06/17
RODM
02/06/17
INITIATION
Target $6
RODM
Buy
NovaBay initiated with a Buy at Rodman & Renshaw
Rodman & Renshaw analyst Raghuram Selvaraju started NovaBay Pharmaceuticals with a Buy rating and $6 price target. The company's risk is mitigated given its "high-growth lead franchise," or Avenova, an eyelid and eyelash cleaner for treatment of blepharitis and dry eye disease, Selvaraju tells investors in a research note.
03/28/17
LDLW
03/28/17
INITIATION
Target $10
LDLW
Buy
NovaBay initiated with a Buy at Laidlaw
Laidlaw analyst Jim Molloy initiated NovaBay with a Buy and a $10 price target saying it represents an exciting turnaround story since their new CEO Mark Sieczkarek transformed their commercial strategy at the beginning of 2016 from a buy and bill sales model to focusing on prescription sales through ophthalmologists. While NovaBay is solely focusing on U.S. Avenova sales for the moment, the approximately $30M recurring patients with blepharitis and dry eye alone attests to the impressive size of the market opportunity, the analyst wrote.
06/05/17
ROTH
06/05/17
INITIATION
Target $5.5
ROTH
Buy
NovaBay initiated with a Buy at Roth Capital
Roth Capital analyst Scott Henry initiated NovaBay with a Buy rating and $5.50 price target.
ACHN Achillion
$3.69

-0.16 (-4.16%)

08/10/17
MAXM
08/10/17
NO CHANGE
Target $7
MAXM
Buy
Achillion price target raised to $7 from $5 at Maxim
Maxim analyst Jason Kolbert is introducing estimates for paroxysmal nocturnal hemoglobinuria in his model for Achillion after the company reported "proof of concept" news for its Factor D program. Adding in the potential for an eventual PHH indication leads him to raise his price target on Achillion shares to $7 from $5. He keeps a Buy rating on the stock.
08/10/17
BARD
08/10/17
DOWNGRADE
Target $5
BARD
Neutral
Achillion downgraded to Neutral at Baird
As reported previously, Baird analyst Brian Skorney downgraded Achillion to Neutral from Outperform. He said the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. Skorney maintained his $5 price target on Achillion shares.
08/11/17
LEER
08/11/17
NO CHANGE
Target $8
LEER
Outperform
Leerink talk with opinion leader suggests Achillion selloff overdone
Leerink analyst Joseph Schwartz says his talk with a key opinion leader who has extensive experience in paroxysmal nocturnal hemoglobinuria clinical development and patient care suggests the recent selloff in shares of Achillion Pharmaceuticals is overdone. The feedback indicates that investors are overemphasizing lactate dehydrogenase data without assigning much credit to the promise that other parameters, such as hemoglobin, fatigue score, and PNH clone size, seem to suggest, Schwartz tells investors in a research note. He reiterates an Overweight rating on shares of Achillion.
G Genpact
$31.06

-0.04 (-0.13%)

09/25/17
BARD
09/25/17
NO CHANGE
Target $34
BARD
Outperform
Genpact could be $40 stock by late 2018, says Baird
Baird analyst David Koning views Genpact as a very good idea in a market where good ideas are difficult to find. The analyst sees the shares as compelling despite headwinds in foreign exchange. He said its valuation is below peers and the company is showing core growth stability. Koning said it is possible the stock could reach $40 by the end of 2018. Koning reiterated his Outperform rating and $34 price target on Genpact.
11/08/17
CANT
11/08/17
NO CHANGE
Target $36
CANT
Overweight
Genpact price target raised to $36 from $32 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi raised his price target for Genpact Limited to $36 following the company's Q3 results and reiterates an Overweight rating on the shares.
11/29/16
PIPR
11/29/16
NO CHANGE
Target $29
PIPR
Overweight
H-1B visa restrictions would be positive for Genpact, says Piper Jaffray
Piper Jaffray analyst George Tong says he's incrementally more positive on the growth prospects for Genpact following a policy analysis of the Trump administration's stance on immigration reform and H-1B visas. A tightening of H-1B visa quotas will constrain the supply of skilled labor and drive upward pressure on wages, prompting employers to consider business process outsourcing as an alternative to organic hiring, Tong tells investors in a research note. Further, the analyst expects Genpact's competitors in IT outsourcing to be disproportionately harmed by restrictions in the H-1B visa program. Tong has an Overweight rating on Genpact with a $29 price target.
08/03/17
WEDB
08/03/17
INITIATION
Target $33
WEDB
Neutral
Genpact initiated with a Neutral at Wedbush
Wedbush analyst Moshe Katri initiated Genpact with a Neutral and a $33 price target.

TODAY'S FREE FLY STORIES

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

, MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

17:56
11/17/17
11/17
17:56
11/17/17
17:56
Hot Stocks
Breaking Hot Stocks news story on Invesco Mortgage, MKS Instruments »

Invesco Mortgage to…

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

17:55
11/17/17
11/17
17:55
11/17/17
17:55
Hot Stocks
MKS Instruments to replace Brocade in S&P 400 at open on 11/22 »

S&P 500 constituent…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

UQM

UQM Technologies

$1.18

0.015 (1.29%)

17:24
11/17/17
11/17
17:24
11/17/17
17:24
Syndicate
Breaking Syndicate news story on UQM Technologies »

UQM Technologies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$238.02

-1.35 (-0.56%)

17:23
11/17/17
11/17
17:23
11/17/17
17:23
Periodicals
Goldman Sachs has $510M lawsuit dismissed, Reuters reports »

A $510M lawsuit that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICL

Vical

$1.94

-0.02 (-1.02%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Breaking Hot Stocks news story on Vical »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:18
11/17/17
11/17
17:18
11/17/17
17:18
Hot Stocks
Ligand director sells 5,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CFO sells 6,559 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

17:17
11/17/17
11/17
17:17
11/17/17
17:17
Hot Stocks
Ligand CEO sells 5,269 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$9.01

0.13 (1.46%)

17:15
11/17/17
11/17
17:15
11/17/17
17:15
Hot Stocks
Breaking Hot Stocks news story on MBIA »

Fine Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBCN

Rubicon

$8.07

0.1218 (1.53%)

17:03
11/17/17
11/17
17:03
11/17/17
17:03
Hot Stocks
Breaking Hot Stocks news story on Rubicon »

Bandera Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCB

Anchor Bancorp

$24.75

-0.1 (-0.40%)

17:02
11/17/17
11/17
17:02
11/17/17
17:02
Hot Stocks
Anchor Bancorp announces stock repurchase program, 10b5-1 trading plan »

Anchor Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:58
11/17/17
11/17
16:58
11/17/17
16:58
Syndicate
Breaking Syndicate news story on Gulf Island Fabrication »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$31.09

0.59 (1.93%)

16:51
11/17/17
11/17
16:51
11/17/17
16:51
Hot Stocks
Mid Penn Bancorp, Scottdale shareholders approve merger »

Mid Penn Bancorp and The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALD

Callidus Software

$28.95

0.3 (1.05%)

16:49
11/17/17
11/17
16:49
11/17/17
16:49
Initiation
Callidus Software initiated at First Analysis »

Callidus Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIFI

Gulf Island Fabrication

$12.30

-0.1 (-0.81%)

16:46
11/17/17
11/17
16:46
11/17/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Gulf Island Fabrication »

Piton Capital Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

16:42
11/17/17
11/17
16:42
11/17/17
16:42
Hot Stocks
General Electric CEO acquires 60,000 common shares »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRE

Northstar Realty Europe

$14.20

0.05 (0.35%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Syndicate
Breaking Syndicate news story on Northstar Realty Europe »

Northstar Realty Europe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

FHN

First Horizon

$18.40

0.1 (0.55%)

, CBF

Capital Bank

$39.95

0.25 (0.63%)

16:33
11/17/17
11/17
16:33
11/17/17
16:33
Hot Stocks
First Horizon, Capital Bank agree to sell two branches to Apex Bank »

First Horizon (FHN) and…

FHN

First Horizon

$18.40

0.1 (0.55%)

CBF

Capital Bank

$39.95

0.25 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$194.25

-0.75 (-0.38%)

16:32
11/17/17
11/17
16:32
11/17/17
16:32
Hot Stocks
Lennox executive sells 2,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TBNK

Territorial Bancorp

$30.99

0.21 (0.68%)

16:31
11/17/17
11/17
16:31
11/17/17
16:31
Hot Stocks
Territorial Bancorp declares special cash dividend of 30c per share »

Payable on December 20.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRTN

Triton International

$40.07

-0.77 (-1.89%)

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Hot Stocks
Triton International's Hanau sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/17/17
11/17
16:30
11/17/17
16:30
Options
Preliminary option volume of 21.1M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.